STOCK TITAN

Oncoinvent ASA Stock Price, News & Analysis

BRRGF OTC Link

Company Description

Oncoinvent ASA (OTC Link: BRRGF) is a publicly traded biotechnology company in the Healthcare sector.

BRRGF stock has gained 41.2% over the past year.

This page provides a comprehensive overview of BRRGF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
0.00%
0.00
Last updated:
+41.24%
Performance 1 year

Oncoinvent ASA (BRRGF) stock. Over the past 12 months, the stock has gained 41.2%.

Latest News

Oncoinvent ASA has 2 recent news articles. Key topics include management, conferences, clinical trial. View all BRRGF news →

SEC Filings

No SEC filings available for BRRGF.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

BRRGF Company Profile & Sector Positioning

Oncoinvent ASA (BRRGF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.

Investors comparing BRRGF often look at related companies in the same sector, including Zivo Bioscience (ZIVOW), Zivo Bioscience Inc (ZIVO), Relief Hldg (RLFTF), MindMaze Therapeutics Holding SA (RLFTY), and Covalon Technologies Ltd (CVALF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BRRGF's relative position within its industry.